New Drug Application Submitted for Investigational Antibiotic Doripenem (PR Newswire via Yahoo! Finance)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., announced that it has submitted a New Drug Application to the United States Food and Drug Administration for doripenem, an investigational carbapenem antibiotic for the treatment of nosocomial pneumonia, a pneumonia that is acquired in a hospital or other healthcare setting.

Wyeth's 'A3/Prime-2' ratings for possible upgrade - Moody's (Sharewatch)
LONDON (Thomson Financial) - Moody's Investors Service said it has placed the ratings of Wyeth, rated 'A3 long term, Prime-2 short term' under review for possible upgrade, following two new FDA approvals and the recent resolution of FDA manufacturing compliance issues.